2022 Speakers

Amanda Garner

Associate Professor

University of Michigan

Amanda Hargrove

Associate Professor – Chemistry

Duke University

Chase Weidmann

Assistant Professor – Biological Chemistry

University of Michigan

Anthony Mustoe

Assistant Professor

Baylor College of Medicine

Anu Bhattacharyya

Executive Director – Biology

PTC Therapeutics

Barak Akabayov

Principal Investigator

Ben-Gurion University of the Negev

Brock Schuman

CEO

Azor Biotek

Can Ozbal

CEO

PureHoney Technologies

Chris Trotta

VP – Discovery Biology

PTC Therapeutics

David Brower

Chief Business Officer

Accent Therapeutics

Dominique Verhelle

Co-Founder & CEO

NextRNA Therapeutics

Elliott Nickbarg

Principal Scientist

Merck & Co

Hashim Al-Hashimi

Professor, Columbia University

Co-Founder, Nymirum

Isaac Kimsey

VP – Drug Discovery

Nymirum

Jana Narasimhan

Executive Director – Pharmacology

PTC Therapeutics

Jennifer Petter

Founder & CIO

Arrakis Therapeutics

John S. Schneekloth, Jr.

Senior Investigator

National Cancer Institute

Julia Weigand

Professor

Philipps-Universität Marburg

Karen Chapman

CSO

Eclipse Bioinnovations

Kevin Pong

CBO

Anima Biotech

Matt Smola

Associate Director - RNA Biology

Ribometrix

Marcel Blommers

Saverna Therapeutics

CSO

Mary McMahon

Head - RNA Biology

ReviR Therapeutics

Matt Woll

VP – Head of Chemistry

PTC Therapeutics

Matthew Disney

Professor & Chair; Department of Chemistry

The Scripps Research Institute

Rabia Khan

CEO

Ladder Therapeutics

Robert Batey

Professor & Associate Chair

University of Colorado Boulder

Paul August

CSO

ReviR Therapeutics

Ryan Potts

Executive Director & Head - Induced Proximity Platform

Amgen

Scott Barraza

Discovery Chemistry Group Leader

PTC Therapeutics

Ioana Panait

Lead Analyst – RNA

Beacon Targeted Therapies

Peter Connolly

Senior Director - Structural Biology

Expansion Therapeutics

Peter Smith

Co-Founder, President & CEO

Remix Therapeutics

Vijay Modur

Head of R&D

Eloxx Pharmaceuticals

Yang Zheng

Head of Business Development

Nymirum

Zbigniew Zaslona

VP – Research Biology

Molecure

Anna Krichevsky

Associate Professor

Brigham and Women’s Hospital & Harvard Medical School

Dave Mauger

Director & Head of Data Science

Arrakis Therapeutics

Zhifeng Yu

Director- Functional Assay and Screening

WuXi AppTec

David Israel

VP - Lead Discovery Sciences

HitGen, Inc.

Paul Agris

Professor Duke

University School of Medicine

REGISTER
PRE-CONFERENCE WORKSHOP DAY